Eswatini
A snapshot of PrEP scale-up, registration and resources for Eswatini.

-
34,000-35,000Estimated Cumulative Number of People Initiating PrEP
Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.
-
14,112PEPFAR PrEP Target in COP 2022
Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.
Data Updated: April 11, 2022
Drug Registration Status
-
Gilead's Truvada (TDF/FTC) registrationApproved
-
Generic versions of TDF/FTC for preventionNot submitted
-
Viiv’s Apretude (CAB for PrEP) RegistrationNot approved
-
IPM’s Dapivirine Ring RegistrationNot approved
Types of Projects
- Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.
- Large-scale implementation initiative — funded/implementer involvement and investment in some or all steps related to comprehensive introduction that may or may not use government clinics as the primary service delivery point – e.g., Kenya’s Jilinde program.
Policy Framework
Funding
- USAID
- The Bill & Melinda Gates Foundation
- PEPFAR
- Nike Foundation
- Heidelberg Institute of Public Health
- Mylan
Resources for Eswatini
- This PrEP ring consultation analysis can support introduction of the dapivirine vaginal ring in Eswatini and is based on several inputs, including secondary research and interviews with key stakeholders in Eswatini.
- Click for the latest information from the Eswatini Ministry of Health.
- A Framework for Scaling Up PrEP can help implementers, government and advocates begin planning for and implementing PrEP programs.